Press Releases July 22, 2026 09:00 AM

Empro Group Inc. Announces Receipt of Nasdaq Delisting Determination Notice

Nasdaq issues delisting determination for Empro Group following SEC trading suspension amid potential market manipulation concerns.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
EMPG

Empro Group Inc., a Malaysian beauty and personal care company listed on Nasdaq, has received a determination notice from Nasdaq to delist its securities. This follows a prior SEC trading suspension due to investigations into possible market manipulation through social media recommendations. Nasdaq cites delays in regulatory filings and discretionary authority to maintain market integrity as reasons for the delisting. While the company denies wrongdoing and will continue operations, it faces the prospect of being removed from Nasdaq pending appeal.

Empro Group Inc. Announces Receipt of Nasdaq Delisting Determination Notice
EMPG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq has determined to delist Empro Group due to discretionary authority under Listing Rule IM-5101-4 and the company's delayed Form 20-F filing.
  • The SEC suspended trading of Empro Group's securities in October 2025 due to potential manipulation from social media driven recommendations.
  • The delisting does not implicate wrongdoing by Empro Group but focuses on regulatory compliance and market integrity concerns.

Selangor, Malaysia, July 22, 2026 (GLOBE NEWSWIRE) -- Empro Group Inc. (Nasdaq: EMPG) (“Empro Group” or the “Company”), a rising beauty and personal care brand headquartered in Malaysia, today announced that on July 16, 2026, the Company received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that Nasdaq has determined to delist the Company’s securities pursuant to its discretionary authority contained in Nasdaq Listing Rule IM-5101-4. In addition, Nasdaq asserts that the Company’s delay in filing Form 20-F for the fiscal year ended December 31, 2025 serves as an independent basis for delisting under Listing Rule 5250(c)(1).

On October 8, 2025, the U.S. Securities and Exchange Commission (the “SEC”) issued an order suspending trading in the Company’s securities because of potential manipulation in the Company’s securities effectuated through recommendations made to investors by unknown persons via social media to purchase the securities of the Company (the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104166.pdf). Following this, Nasdaq halted trading in the Company’s securities and has now determined to delist the Company’s securities pursuant to its discretionary authority set forth in Nasdaq Listing Rule IM-5101-4.

Nasdaq Listing Rule 5101 provides Nasdaq with “broad discretionary authority over the initial and continued listing of securities in Nasdaq in order to maintain the quality of and public confidence in its market, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, and to protect investors and the public interest.” Listing Rule IM-5101-4 further expands on this authority, allowing Nasdaq “to exercise discretion to delist a company from Nasdaq based on the potential for one or more third parties to engage in misconduct impacting a company’s securities where the SEC has implemented a temporary trading suspension.”

Following the Notice, the Company has and will continue to consult with its legal counsel and other advisors to evaluate its next steps and will make further announcements as and when appropriate. Unless the Company requests an appeal of this determination by July 23, 2026, trading of the Company’s securities will be suspended at the opening of business on July 27, 2026. Nasdaq will subsequently file a Form 25-NSE with the SEC, which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

To date, Nasdaq has not communicated any findings or determination that the Company engaged in wrongdoing in connection with the recent trading activity in the Company’s securities or otherwise. The delisting determination does not affect the Company’s ongoing business operations or financial condition, and the Company will continue to conduct its business in the ordinary course.

About Empro Group Inc.

Empro Group Inc. is a rising beauty and personal care brand headquartered in Malaysia. Evolving from its origins in Malaysia’s eyebrow embroidery space, Empro Group has grown into a trusted name across three core pillars: cosmetics, skincare, and healthcare. With a growing presence across Southeast Asia and Europe, Empro Group Inc. remains dedicated to offering accessible, quality self-care solutions while staying true to its humble beginnings. For more information please visit: https://www.empro.my/.

Forward-Looking Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These forward-looking statements are subject to uncertainties and risks, including, without limitation, those risk factors that are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Investor Relations
Visit emproinc.co
Or contact us at [email protected]


Risks

  • Trading suspension and delisting may significantly reduce liquidity and investor confidence impacting stock valuation.
  • Potential impacts on the company's ability to raise capital in US markets due to loss of Nasdaq listing.
  • Ongoing uncertainty related to regulatory investigations and market perceptions could harm the beauty and personal care sector exposure in U.S. equity markets.

More from Press Releases

C&F Announces Expansion into Lynchburg Market Jul 22, 2026 OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director Jul 22, 2026 Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years Jul 22, 2026 CrowdStrike and Cerebras Partner to Power AI Detection and Response on the World's Fastest Inference Jul 22, 2026 TeraWulf Schedules Conference Call for Second Quarter 2026 Financial Results Jul 22, 2026